These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1141709)

  • 41. Proliferation-dependent effect of skin extracts (chalone) on mouse epidermal cell flux at the G1-S, S-G2 and G2-M transitions.
    Elgjo K; Clausen OP
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 42(2):143-51. PubMed ID: 6133388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Disappearance of psoriactic lesions under the effect of anthralin].
    Chowaniec O
    Przegl Dermatol; 1976; 63(5):665-71. PubMed ID: 1005760
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibition of DNA replication and repair cultured humans cells by anthralin or danthron.
    Clark JM; Hanawalt PC
    Br J Dermatol; 1981 Aug; 105 Suppl 20():49-50. PubMed ID: 7284265
    [No Abstract]   [Full Text] [Related]  

  • 44. Incorporation of 3H-thymidine into DNA: inhibition by dithranol and its di- and triacetate.
    Plumier E; Wappes B; Wiegrebe W
    Arch Dermatol Res; 1984; 276(6):406-8. PubMed ID: 6517613
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibition of DNA replication and repair by anthralin or danthron in cultured human cells.
    Clark JM; Hanawalt PC
    J Invest Dermatol; 1982 Jul; 79(1):18-22. PubMed ID: 7086172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antioxidant and prooxidant effects of the antipsoriatic compound anthralin in skin and subcellular fractions.
    Fuchs J; Nitschmann W; Packer L
    Adv Exp Med Biol; 1990; 264():537-41. PubMed ID: 2244537
    [No Abstract]   [Full Text] [Related]  

  • 47. Elimination of metabolic cooperation is associated with the tumor promoters, oleic acid and anthralin.
    Trosko JE; Jone C; Aylsworth C; Tsushimoto G
    Carcinogenesis; 1982; 3(9):1101-3. PubMed ID: 7139869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calmodulin inhibition by anthralin? Investigations in vitro and in vivo.
    Wollina U; Klinger R; Wetzker R; Knopf B
    Dermatologica; 1989; 179(2):61-3. PubMed ID: 2529149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regenerative proliferation of mouse epidermal cells following adhesive tape stripping. Micro-flow fluorometry of isolated epidermal basal cells combined with 3H-TdR incorporation and a stathmokinetic method (colcemid).
    Clausen OP; Lindmo T
    Cell Tissue Kinet; 1976 Nov; 9(6):573-87. PubMed ID: 1000570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a therapeutic concentration of dithranol in the mouse-tail test.
    Hofbauer M; Dowd PM; Atkinson J; Whitefield M; Greaves MW
    Br J Dermatol; 1988 Jan; 118(1):85-9. PubMed ID: 3342179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin).
    Tucker WF; MacNeil S; Dawson RA; Tomlinson S; Bleehen SS
    J Invest Dermatol; 1986 Aug; 87(2):232-5. PubMed ID: 3016102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cornified envelope formation by anthralin, simple analogues, and related anthracenones.
    Müller K; Reindl H
    Arch Pharm (Weinheim); 2001 Mar; 334(3):86-92. PubMed ID: 11315339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anthralin: historical and current perspectives.
    Ashton RE; Andre P; Lowe NJ; Whitefield M
    J Am Acad Dermatol; 1983 Aug; 9(2):173-92. PubMed ID: 6309924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An EPR method for estimating activity of antioxidants in mouse skin using an anthralin-derived radical model.
    Kawai S; Matsumoto K; Utsumi H
    Free Radic Res; 2010 Mar; 44(3):267-74. PubMed ID: 20001648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Study on the mode of action of dithranol: increased lipid peroxidation and enzyme inhibition].
    Diezel W; Meffert H; Sönnichsen N
    Dermatologica; 1975; 150(3):154-62. PubMed ID: 125665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of antipsoriasis drugs and metabolic inhibitors on the growth of epidermal cells in culture.
    Klem EB
    J Invest Dermatol; 1978 Jan; 70(1):27-32. PubMed ID: 618977
    [No Abstract]   [Full Text] [Related]  

  • 57. [Glucose-6-phosphate dehydrogenase and topical antipsoriatics. A comparison of anthralin, anthralin-monoacetate, anthralin-diacetate, anthralin-triacetate and 6-hydroxy-2-oxobenzoxathiole (author's transl)].
    Raab W; Siber H
    Arch Dermatol Forsch; 1974; 249(2):179-89. PubMed ID: 4418435
    [No Abstract]   [Full Text] [Related]  

  • 58. Growth kinetics in newborn mouse epidermis: response to epidermal chalone.
    Elgjo K; Cromarty A
    Virchows Arch B Cell Pathol; 1977 Jun; 24(2):101-8. PubMed ID: 142357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cell population kinetics and the cell population mechanisms of the circadian rhythm of proliferative activity in mouse esophageal epithelium].
    Rybakov VP; Romanov IuA; Timofeev AV
    Tsitologiia; 1979 Apr; 21(4):401-7. PubMed ID: 452111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. INFLUENCE OF STRESS ON THE DIURNAL RHYTHM IN THE MITOTIC ACTIVITY IN THE EPIDERMIS OF HAIRLESS MICE.
    KREYBERG L; EVENSEN A; IVERSEN OH
    Acta Pathol Microbiol Scand; 1965; 64():176-84. PubMed ID: 14329856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.